Viable myocardium: How much is enough? A comparison of viability by comparative imaging techniques to assess the quantity and functionality of ischemic myocardium

Echocardiography

Volumn 22, Issue 1, 2005, Pages 59-70

  Salazar, Holger P ^a,c   Talano, James V ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b DEPARTMENT OF COLORECTAL SURGERY   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dobutamine stress echocardiogram; Ischemic cardiomyopathy; Positron emission tomography and magnetic resonance imaging; Thallium 201 single photon emission computed tomography; Viable myocardium

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE; THALLIUM 201;

CARDIOMYOPATHY; CELL METABOLISM; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MYOCARDIAL HIBERNATION; MYOCARDIUM VIABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; STUNNED HEART MUSCLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; CARDIOVASCULAR SYSTEM EXAMINATION; HEART; HEART MUSCLE ISCHEMIA; PATHOPHYSIOLOGY;

DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HEART; HUMANS; MYOCARDIAL ISCHEMIA; SENSITIVITY AND SPECIFICITY; TISSUE SURVIVAL;

EID: 13244250038     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0742-2822.2005.04029.x     Document Type: Review

References (77)

1. Massie BM, Shah NB: Evolving trends in the epidemiologic factors of heart failure: Rationale for preventing strategies and comprehensive disease management. Am Heart J 1997;133:703-712.
2. Ho KKL, Pimsky JL, Kannel WB, et al: The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993;22(Suppl. A):6A-13A.
3. Chatterjee K, Swan HJC, Parmley WW, et al: Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease: With and without previous myocardial infarction. Circulation 1973;47:276-286.
4. Rees G, Bristow JD, Krembov EL, et al: Influence of aortocoronary bypass surgery and left ventricular performance. N Engl J Med 1971;284:1116-1120.
5. Alderman EL, Fisher LD, Litwin P, et al: Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-795.
6. Horn HR, Teichholz LE, Cohn PF, et al: Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic cathecholamine: The epinephrine ventriculogram. Circulation 1974;49:1063-1071.
7. Diamond GA, Forrester JS, deLuz PL, et al: Post extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 1978;95:204-209.
8. Rahimtoola SH: The hibernating myocardium. Am Heart J 1989;11:211-221.
9. Elsasser A, Muller KD, Skwara W, et al: Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death. J Am Coll Cardiol 2002;39:1189-1198.
10. 2+ ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol 1999;277:H1418-H1428.
11. Canty JM Jr, Fallavollita JA: Chronic hibernation and chronic stunning: A continuum. J Nucl Cardiol 2000;7:509-527.
12. Heusch G, Rose J, Skyschally A, et al: Calcium responsiveness in regional short-term hibernation and stunning in the in-situ porcine heart: Inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation 1996;93:1556-1566.
13. Shan K, Bick RJ, Poindexter BJ, et al: Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial function. Circulation 2000;102:2599-2606.
14. Camici P, Wijns W, Borgers M, et al: Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease. Circulation 1997;96:3205-3214.
15. Borges M, Thone F, Wouters L, et al: Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: Chronic hibernation? Cardiouasc Pathol 1993;2:237-245.
16. Flemeng W, Suy R, Schwartz F, et al: Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: Determinants of reversible segmental asynergy postrevascularization surgery. Am Heart J 1981;102:846-857.
17. Schultz R, Guth BD, Pieper K, et al: Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: A model of short term hibernation. Circ Res 1992;70:1282-1295.
18. Elsasser A, Schlepper M, Klovekorn WP, et al: Hibernating myocardium: An incomplete adaptation to ischemia. Circulation 1997;96:2920-2931.
19. Kalra DK, Zhu X, Ramchandani MK, et al: Increased myocardial gene expression of tumor necrosis factor-α and nitric oxide synthase-2. A potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation 2002;105:1537-1540.
20. Oral H, Dorn GW II, Mann DL: Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocite. J Biol Chem 1997;272:4836-4842.
21. Ungureanu-Longrois D, Balligand JL, Simmons WW, et al: Induction of nitric oxide synthase activity by cytokines in ventricular myocites is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ Res 1995;77:494-502.
22. Sawyer DB, Loscalzo J: Myocardial hibernation: Restorative or preterminal sleep? Circulation 2002;105:1517-1519.
23. Liu R, Buettner GR, Oberley LW: Oxygen free radicals mediate the induction of manganese superoxide dysmutase gene expression by TNF-α. Free Radic Biol Med 2000;28:1197-1205.
24. Yamashita N, Hoshida S, Otu K, et al: The involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol 2000;131:415-422.
25. Recchia FA, McConnell PI, Bernstein RD, et al: Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998;83:969-979.
26. Heusch G, Post H, Michel MC, et al: Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res 2000;87:146-152.
27. Perrone-Filardi P, Bacharach SL, Dilsizian V, et al: Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1992;20:161-168.
28. Vatner SF: Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res 1980;47:201-207.
29. Canty JM Jr: Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unasthesized dog. Circ Res 1998;63:821-836.
30. Gallagher KP, Matsuzaki M, Koziol JA, et al: Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. Am J Physiol 1984;247:H727-H738.
31. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;75:1124-1136.
32. Bolli R, Zughaib M, Li X-Y, et al: Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial stunning. J Clin Invest 1995;96:1066-1084.
33. Takano H, Manchikalapudi S, Tang X-L, et al: Nitric acid synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbit. Circulation 1998;98:441-449.
34. Stillman AE, Wilke N, Jerosch-Herold M: Myocardial viability. Radiol Clin North America 1999;37:361-378.
35. Kloner RA, Bolli R, Marban E, et al: Medical and cellular implications of stunning, hibernation and preconditioning: An NHLBI Workshop. Circulation 1998;97:1848-1867.
36. Ross J Jr: Myocardial perfusion-contraction matching: Implications for coronary heart disease and hibernation. Circulation 1991;83:1076-1082.
37. Vanoverschelde JL, Wijns W, Depre C, et al: Mechanisms of chronic regional postischemic dysfunction in humans: New insights for the study of noninfarcted collateral dependent myocardium. Circulation 1993;87:1513-1523.
38. Ferrari R, Ferrari F, Benigno M, et al: Hibernating myocardium: Its pathophysiology and clinical role. Mol Cell Biochem 1998;186:195-199.
39. Elefteriades JA, Tolis G Jr, Levi E, et al: Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22:1411-1417.
40. Bonow RO: The hibernating myocardium: Implications for management of congestive heart failure. Am J Cardiol 1995;75:17A-25A.
41. Gioia G, Powers J, Heo J, et al: Pronostic value of rest redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995;75:759-762.
42. DiCarli MF, Davidson M, Little R, et al: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-533.
43. Bodenheimer MM, Banka VS, Hermann GA, et al: Reversible asynergy: Histopathologic and electrocardiographic correlations in patients with coronary artery disease. Circulation 1976;53:792-796.
44. Brunken R, Tillisch J, Schwaiger W, et al: Regional perfusion, glucose metabolism and wall motions in patients with chronic electrocardiographic Q wave infarction: Evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986;73:951-963.
45. Srinivasan G, Kitsiou AN, Bacharach SL, et al: 18-F-deoxyglucose SPECT: Can it replace PET and thallium SPECT for assessment of myocardial viability? Circulation 1998;97:843-850.
46. Bax JJ, Cornel JH, Visser FC, et al: Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol 1997;30:1377-1383.
47. Bax JJ, Wijns W, Cornel JH, et al: Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease. J Am Coll Cardiol 1997;3:1451-1460.
48. Bax JJ, Visser FC, Blanksma PK, et al: Comparison of myocardial uptake of F-18-fluorodeoxyglucose imaged with positron emission tomography and single photon emission computed tomography. J Nucl Med 1996;37:988-995.
49. Bax JJ, Poldermans D, Visser FC, et al: Delayed recovery of hibernating myocardium after surgical revascularization: Implication for discrepancy between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability. J Nucl Cardiol 1999;6:685-687.
50. Kim RJ, Wu E, Rafael A, et al: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
51. Task force of the European Society of Cardiology, in collaboration with the Association of European Pediatric Cardiologists: The clinical role of magnetic resonance in cardiovascular disease. Eur Heart J 1998;19:19-39.
52. Stillman AE, Wilke N, Jerosh-Herold M: Myocardial viability. Radiol Clin North America 1999;37:361-378.
53. Baer FM, Voth E, Schneider CA, et al: Comparison of low dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with 18-FDG in patients with chronic coronary artery disease: A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-1015.
54. Bonow RO: Identification of viable myocardium. Circulation 1996;94:2674-2680.
55. Perrone-Filardi P, Pare L, Prastaro M, et al: Assessment of myocardial viability in patients with chronic coronary artery disease: Rest-4 hour-24 hour T1-201, tomography versus dobutamine echocardiography. Circulation 1996;94:2712-2719.
56. Beller GA: Comparison of 201 Tl scintigraphy and low dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Circulation 1996;94:2681-2684.
57. 201Tl single-photon emission computed tomography. Circulation 1995;91:2748-2752.
58. Cornel JH, Bax JJ, Elhendy A, et al: Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium. J Nucl Cardiol 1999;6:383-388.
59. Vanderschelde JJ, D'Hondt AM, Marwick T, et al: Head-to-head comparison of exercise-redistribution-reinjection thallium single photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432-442.
60. Bax JJ, Cornel JH, Visser FC, et al: Prediction of recovery of regional ventricular dysfunction following revascularization: Comparison of F-18-fluorodeoxyglucose SPECT, thallium stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558-564.
61. Panza JA, Dilsizian V, Laurienzo JM, et al: Relation between thallium uptake and contractile response to dobutamine implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995;91:990-998.
62. Perrone-Filardi P, Pace L, Prastars H, et al: Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995;91:2556-2565.
63. Baumgarther H, Porenta G, Lau YK, et al: Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: Correlation with histopathology in explanted hearts. J Am Coll Cardiol 1998;32:1701-1708.
64. Grayburn PA: How good is echocardiography at assessing myocardial viability? Am J Cardiol 1995;76:1183-1184.
65. Kaul S: There may be more to myocardial viabilty than meets the eye. Circulation 1995;92:2790-2793.
66. Edwards NC, Sinusas AJ, Bergin TD, et al: Influence of subendocardial ischemia on transmural myocardial function. Am J Physiol 1992;262:H568-H576 (Heart Circ Physiol 31).
67. Christian TF, Miller TD, Hodge DO, et al: An estimate of the prevalence of reversible left ventricular dysfunction in patients referred for coronary artery bypass surgery. J Nucl Cardiol 1996;4:140-146.
68. Luu M, Stevenson LW, Brunken RC, et al: Delayed recovery of revascularized myocardium after referral for cardiac transplantation. Am Heart J 1990;119:668-670.
69. Auerbach MA, Schoder H, Hoh C, et al: Prevalence of myocardial viability is detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999;99:2921-2926.
70. Ferrari R, La Canna G, Giubbini R, et al: Hibernating myocardium. In Yacoub, Pepper (eds.): Annual of Cardiac Surgery. 1994, pp. 28-32.
71. Tillisch J, Brunken R, Marshall R, et al: Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
72. Louie HW, Laks H, Milgater E, et al: Ischemic cardiomyopathy: Criteria for coronary revascularization and cardiac transplantation. Circulation 1991;84(Suppl. III):III290-III295.
73. DiCarli MF, Asgarzadie F, Schelbert HR, et al: Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-3444.
74. Hausmann H, Topp H, Siniawski H, et al: Decision-making in end-stage coronary artery disease: Revascularization or heart transplantation. Ann Thorac Surg 1997;64:1296-1302.
75. Go RT, MacIntyre WJ, Cook SA, et al: The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction. J Nucl Cardiol 1996;3:96-104.
76. Baxx JJ, Visser FC, Poldermans D, et al: Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 2001;42:79-86.
77. Cerqueira MD, Weissman NJ, Dilsizian Z, et al: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-542.